Cargando…
Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783966/ https://www.ncbi.nlm.nih.gov/pubmed/33402194 http://dx.doi.org/10.1186/s13046-020-01805-6 |
| _version_ | 1783632208211214336 |
|---|---|
| author | Ma, Liying Bian, Xing Lin, Wenchu |
| author_facet | Ma, Liying Bian, Xing Lin, Wenchu |
| author_sort | Ma, Liying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7783966 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77839662021-01-05 Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer Ma, Liying Bian, Xing Lin, Wenchu J Exp Clin Cancer Res Correction BioMed Central 2021-01-05 /pmc/articles/PMC7783966/ /pubmed/33402194 http://dx.doi.org/10.1186/s13046-020-01805-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Ma, Liying Bian, Xing Lin, Wenchu Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer |
| title | Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer |
| title_full | Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer |
| title_fullStr | Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer |
| title_full_unstemmed | Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer |
| title_short | Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer |
| title_sort | correction to: the dual hdac-pi3k inhibitor cudc-907 displays single-agent activity and synergizes with parp inhibitor olaparib in small cell lung cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783966/ https://www.ncbi.nlm.nih.gov/pubmed/33402194 http://dx.doi.org/10.1186/s13046-020-01805-6 |
| work_keys_str_mv | AT maliying correctiontothedualhdacpi3kinhibitorcudc907displayssingleagentactivityandsynergizeswithparpinhibitorolaparibinsmallcelllungcancer AT bianxing correctiontothedualhdacpi3kinhibitorcudc907displayssingleagentactivityandsynergizeswithparpinhibitorolaparibinsmallcelllungcancer AT linwenchu correctiontothedualhdacpi3kinhibitorcudc907displayssingleagentactivityandsynergizeswithparpinhibitorolaparibinsmallcelllungcancer |